Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.74 |
| ▸ | CRYAB | P02511 | 3/20 | 0.74 |
| ▸ | USP2 | O75604 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | FNTA | P49354 | 1/20 | 0.70 |
| ▸ | FNTB | P49356 | 1/20 | 0.70 |
| ▸ | PTGES | O14684 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.59 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.59 |
| ▸ | PREP | P48147 | 1/20 | 0.57 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.57 |
| ▸ | CRYAA | P02489 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2370125 | 0.85 | MAPT (0.78) | MAPTCRYABUSP2ALDH1A1CYP3A4 | |
| Lanosterol SCHEMBL19194030 | 0.85 | MAPT (1.00) | MAPTCRYABUSP2ALDH1A1CYP3A4 | |
| Lanosterol SCHEMBL14536063 | 0.85 | MAPT (1.00) | MAPTCRYABUSP2ALDH1A1CYP3A4 | |
| SCHEMBL16249832 | 0.85 | MAPT (0.78) | MAPTCRYABUSP2ALDH1A1CYP3A4 | |
| Lanosterol SCHEMBL1696473 | 0.85 | MAPT (1.00) | MAPTCRYABUSP2ALDH1A1CYP3A4 | |
| Lanosterol SCHEMBL14360758 | 0.85 | MAPT (1.00) | MAPTCRYABUSP2ALDH1A1CYP3A4 | |
| Lanosterol SCHEMBL2154745 | 0.85 | MAPT (1.00) | MAPTCRYABUSP2ALDH1A1CYP3A4 | |
| Lanosterol SCHEMBL145835 | 0.85 | MAPT (1.00) | MAPTCRYABUSP2ALDH1A1CYP3A4 | |
| Lanosterol SCHEMBL21348006 | 0.85 | MAPT (1.00) | MAPTCRYABUSP2ALDH1A1CYP3A4 | |
| Lanosterol SCHEMBL145834 | 0.85 | MAPT (1.00) | MAPTCRYABUSP2ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118108875-A | Hyaluronic acid derivative composition, pharmaceutical composition, and hyaluronic acid derivative-pharmaceutical conjugate composition | 旭化成株式会社 | 2024-05-31 | — | — | CN | claimed |
| CN-118027246-A | Hyaluronic acid derivative, pharmaceutical composition, and hyaluronic acid derivative-pharmaceutical combination | 旭化成株式会社 | 2024-05-14 | — | — | CN | claimed |
| US-20200032262-A1 | NOVEL TECHNIQUE FOR TREATING CANCER USING STRUCTURALLY-REINFORCED S-TUD | GENEDESIGN, INC. (JP) | 2020-01-30 | — | — | US | claimed |
| US-9708628-B2 | Cationic lipid having improved intracellular kinetics | NOF CORPORATION (JP) | 2017-07-18 | — | — | US | claimed |
| WO-2008155141-A2 | NOVEL FACULTATIVE CATONIC STEROLS | NOVOSOM AG (DE) | 2008-12-24 | — | — | WO | claimed |
| EP-1345632-A2 | ABSORBENT ARTICLES WITH NON-AQUEOUS COMPOSITIONS CONTAINING BOTANICALS | Kimberly-Clark Worldwide, Inc. (US) | 2003-09-24 | — | — | EP | claimed |
| WO-2002051456-A2 | ABSORBENT ARTICLES WITH NON-AQUEOUS COMPOSITIONS CONTAINING BOTANICALS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2002-07-04 | — | — | WO | claimed |
| US-5759565-A | DRUG FOR NASAL ADMINISTRATION | NOVARTIS CORPORATION (US) | 1998-06-02 | — | — | US | claimed |
| CN-118108876-A | Hyaluronic acid derivative, pharmaceutical composition, and hyaluronic acid derivative-pharmaceutical combination | 旭化成株式会社 | 2024-05-31 | — | — | CN | disclosed |
| CN-118108877-A | Hyaluronic acid derivative composition, pharmaceutical composition, and hyaluronic acid derivative-pharmaceutical conjugate composition | 旭化成株式会社 | 2024-05-31 | — | — | CN | disclosed |
| CN-118108875-A | Hyaluronic acid derivative composition, pharmaceutical composition, and hyaluronic acid derivative-pharmaceutical conjugate composition | 旭化成株式会社 | 2024-05-31 | — | — | CN | disclosed |
| EP-4368657-A1 | PH-RESPONSIVE LIPID DERIVATIVE | NOF Corporation (JP) | 2024-05-15 | — | — | EP | disclosed |
| CN-118027246-A | Hyaluronic acid derivative, pharmaceutical composition, and hyaluronic acid derivative-pharmaceutical combination | 旭化成株式会社 | 2024-05-14 | — | — | CN | disclosed |
| US-20240131049-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | ORNA THERAPEUTICS, INC. | 2024-04-25 | — | — | US | disclosed |
| US-20020143160-A1 | High purity polysaccharide containing hydrophobic group and process for producing it | NOF CORPORATION | 2002-10-03 | — | — | US | disclosed |
| EP-1166745-A1 | COSMETICS CONTAINING POLYSACCHARIDE-STEROL DERIVATIVES | NOF CORPORATION (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1113023-A1 | METHOD OF FORMING AGGLOMERATES OF POLYSACCHARIDE WITH HYDROPHOBIC GROUPS | NOF CORPORATION (JP) | 2001-07-04 | — | — | EP | disclosed |
| WO-2000064407-A1 | ABSORBENT TISSUES PROVIDING SKIN BARRIER ENHANCEMENT | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2000-11-02 | — | — | WO | disclosed |
| EP-1026174-A1 | HIGH-PURITY POLYSACCHARIDE CONTAINING HYDROPHOBIC GROUPS AND PROCESS FOR PRODUCING THE SAME | NOF CORPORATION (JP) | 2000-08-09 | — | — | EP | disclosed |
| EP-0007474-B1 | STEROLINHEMIESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Roecar Holdings (Netherlands Antilles) N.V. (AN) | 1985-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240131049-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | RTCB, HNRNPA1, HNRNPAB | MAPT 4190/4885CRYAB 2007/4885USP2 3455/4885 |
| US-20200032262-A1 | NOVEL TECHNIQUE FOR TREATING CANCER USING STRUCTURALLY-REINFORCED S-TUD | SLIRP, HNRNPDL, KHDRBS1 | MAPT 1287/4885CRYAB 2508/4885USP2 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.